English
Alkem Laboratories Q4 Results
- BSE: 539523
- NSE: ALKEM
- ISIN: INE540L01014
- Sector: Biotechnology & Drugs
BSE
5,593
-96.30 (-1.69%)
-96.30 (-1.69%)Volume1.74 K
Updated: Mon 8 Dec, 2025 | 15:29:00
NSE
5,599.50-76.00 (-1.34%)
-76.00 (-1.34%)Volume1.35 L
Updated: Mon 8 Dec, 2025 | 15:17:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Alkem Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2,864.95 | 2,700.17 | 6.10% | 2,613.63 | 9.62% |
| Depreciation/ Amortization | 112.49 | 85.28 | 31.91% | 83.43 | 34.83% |
| Operating Income | 278.80 | 674.11 | -58.64% | 322.19 | -13.47% |
| Net Income | 305.86 | 625.82 | -51.13% | 293.56 | 4.19% |
| Other Operating Expenses Total | 856.83 | 785.75 | 9.05% | 920.61 | -6.93% |
| Net Income Before Taxes | 395.72 | 731.07 | -45.87% | 367.34 | 7.73% |
| Total Revenue | 3,143.75 | 3,374.28 | -6.83% | 2,935.82 | 7.08% |
| Selling/ General/ Admin Expenses Total | 616.35 | 624.81 | -1.35% | 505.83 | 21.85% |
| Diluted Normalized EPS | 25.58 | 52.34 | -51.13% | 24.55 | 4.18% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.